Main Topics & Key Insights:
The Blurred Line Between Feed and Drugs: Dr. Pearson begins by defining the role of feed, from basic sustenance to promoting health and athletic performance. She illustrates how nutrition can manage health conditions like arthritis, anxiety, and insulin resistance. Consequently, this places nutraceuticals in a ‘gray zone’ between feed and drugs. This zone lacks the rigorous evaluation requirements of pharmaceuticals. As a result, it leads to significant industry challenges.
The Scale of the Joint Supplement Market:
Osteoarthritis is identified as the most common joint disease in companion animals. It affects one in four dogs (over 80% in geriatric dogs) and up to 90% of cats over 12. In horses, osteoarthritis is responsible for 60% of performance-limiting conditions. Because of this, a multi-billion dollar global pet supplement market has emerged, with joint health being the largest sector. Despite this growth, consumer choices are often driven by marketing and perception rather than scientific proof. Many owners continue to buy products even when they see no difference.
Perception vs. Reality – The Science-Fiction Gap:
Dr. Pearson highlights the industry’s use of ‘science-y’ marketing to build consumer trust. She presents a stark study from the University of Guelph that analyzed off-the-shelf glucosamine supplements. The study revealed that the actual content varied wildly from the label claim—from 0% to over 220%. This demonstrates a critical lack of quality control. Furthermore, it shows the potential for wasting money or even causing harm through accidental overdose. She also calls out the practice of ‘borrowed science,’ where companies use unrelated research to support their product claims. However, these companies do not test the final formulation on the target species.
A Data-Driven Model for the Future:
To counter these issues, Dr. Pearson proposes a new model for the industry: Data (objective research) → Evidence → Information (analysis) → Knowledge (contextualization) → Wisdom (collective understanding). This framework emphasizes the necessity of product-specific, species-specific, peer-reviewed research.
Review of Scientific Evidence:
Dr. Pearson reviews studies on several ingredients:
MSM: A study showed MSM (especially with Vitamin C) increased antioxidant enzyme activity in exercising horses. This may help manage oxidative stress.
Glucosamine & Chondroitin: Multiple studies, including one on an experimental model of osteoarthritis in horses, showed no significant effect on lameness or biomarkers of inflammation compared to a placebo.
Herbal Supplements: A study on a multi-herb blend for canine osteoarthritis also showed no significant effect. However, research from her own lab on a mint variant high in rosemaric acid showed a significant reduction in inflammatory markers in horses.
Spirulina & Omega-3s: Recent research indicates that spirulina and omega-3 oils (rich in DHA) can increase the production of resolvins, compounds that help in the *resolution* of inflammation. This suggests they don’t just block inflammation but help the body recover from it more efficiently. Studies show increased resolvin levels and reduced joint swelling.
Safety and Cost:
The presentation notes the wide variability in the cost of supplements. It also addresses safety, noting that while glucosamine appears safe for humans with diabetes, a case study of a dog overdosing on a joint supplement highlights potential toxicity risks. A major indirect risk is delaying more appropriate veterinary treatment by relying on unproven products.
Q&A Session:
Dr. Pearson answers audience questions, recommending oil-based supplements (specifically those with DHA for its role in inflammation resolution) as having the most consistent evidence across species. She discusses the challenges of conducting research in companion animals but notes it is not insurmountable. When asked how consumers can verify ‘science-backed’ claims, she advises them to directly ask companies for their peer-reviewed, product-specific research. A company that has invested in it will be eager to share it.
Conclusion:
The webinar concludes with three key take home messages: 1) Evidence for most joint products is limited and often indirect. 2) Dose, formulation, and product quality are critical for efficacy. 3) Consumers and professionals should guide their decisions with science, not the perception of science, by demanding high-quality, product-specific research.
Science‑Backed Ingredients Start Here
At Balchem, we believe nutrition solutions should be guided by evidence—not perception. OptiMSM, a highly purified form of methylsulfonylmethane, is trusted globally for its quality, consistency, and scientific foundation.
Learn how OptiMSM® supports joint health through science‑based nutrition. 👉 OptiMSM – Animal Nutrition & Health
